The DOI matches its Crossref record; 268 of the 268 references it cites were found in a registry or an index.
Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–268 of 268
Garcı́a-Román, N., Alvarez, A. M., Toro, M. J., Montes, A., & Lorenzo, M. J. V. (2001) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0904 · Cited by 77
Lovastatin-induced E2F-1 modulation and its effect on prostate cancer cell death
Park, C. (2001) · Carcinogenesis · doi:10.1093/carcin/22.10.1727 · Cited by 77
Ganné, F., Vasse, M., Beaudeux, J., Peynet, J., François, A., Mishal, Z., Chartier, A., Tobelem, G., Vannier, J., Soria, J., et al. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614087 · Cited by 73
Role of Rho Protein in Lovastatin-Induced Breakdown of Actin Cytoskeleton
Koch, G. E., Benz, C., Schmidt, G., Olenik, C., & Aktories, K. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37069-7 · Cited by 73
Soma, M. R., Pagliarini, P., Butti, G., Paoletti, R., Paoletti, P., & Fumagalli, R. (1992) · PubMed · Cited by 70
Wang, I.-K., Lin‐Shiau, S., & Lin, J. (2000) · Oncology · doi:10.1159/000012168 · Cited by 70
Geranylgeraniol Overcomes the Block of Cell Proliferation by Lovastatin in C6 Glioma Cells
Crick, D. C., Andres, D., Danesi, R., Macchia, M., & Waechter, C. J. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70062397.x · Cited by 70
The farnesyltransferase inhibitor L744,832 reduces hypoxia in tumors expressing activated H-ras.
Moyal, E. C., Evans, S. M., Koch, C. J., Muschel, R. J., McKenna, W. G., Wu, J., & Bernhard, E. J. (2001) · PubMed · Cited by 70
Nørgaard, P. H., Law, B. K., Joseph, H., Page, D. L., Shyr, Y., Mays, D., Pietenpol, J. A., Kohl, N. E., Oliff, A. I., Coffey, R. J., et al. (1999) · PubMed · Cited by 67
Narisawa, T., Morotomi, M., Fukaura, Y., Hasebe, M., Ito, M., & Aizawa, R. (1996) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1996.tb02103.x · Cited by 66
Dricu, A., Wang, M., Hjertman, M., Malec, M., Blegen, H., Wejde, J., Carlberg, M., & Larsson, O. (1997) · Glycobiology · doi:10.1093/glycob/7.5.625 · Cited by 65
Weiss, R. H., RAMIREZ, A., & Joo, A. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1091880 · Cited by 64
Interaction of cytosine arabinoside and lovastatin in human leukemia cells
Holstein, S. A., & Hohl, R. J. (2001) · Leukemia Research · doi:10.1016/s0145-2126(00)00162-4 · Cited by 63
Pro-apoptotic effect of fluvastatin on human smooth muscle cells
Buemi, M., Allegra, A., Senatore, M., Marino, D., Medici, M. A., Aloisi, C., Pasquale, G. D., & Corica, F. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00122-3 · Cited by 61
WHO clofibrate/cholesterol trial: clarifications
Heady, J. A., Morris, J. N., & Oliver, M. F. (1992) · The Lancet · doi:10.1016/0140-6736(92)92588-7 · Cited by 60
Thompson, K., Dunford, J. E., Ebetino, F. H., et al. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6289 · Cited by 53
Awada, A. H., Eskens, F. A. L. M., Piccart, M. J., Cutler, D. L., van der Gaast, A., Bleiberg, H., Wanders, J., Faber, M. N., Statkevich, P., Fumoleau, P., et al. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00379-9 · Cited by 52
McGuire, T. F., Xu, X. Q., Corey, S. J., Romero, G. G., & Sebti, S. M. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2472 · Cited by 51
Wang, W., Collie-Duguid, E. S. R., & Cassidy, J. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03575-5 · Cited by 51
Inhibitory effect of Lovastatin on spontaneous metastases derived from a rat lymphoma
Matar, P., Rozados, V. R., Binda, M. M., Roggero, E., Bonfil, R. D., & Scharovsky, O. G. (1999) · Clinical & Experimental Metastasis · doi:10.1023/a:1026448026716 · Cited by 49
McGuire, T. F., Corey, S. J., & Sebti, S. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41512-8 · Cited by 47
Liu, A., & Prendergast, G. C. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02003-2 · Cited by 47
Law, B. K., Nørgaard, P. H., Gnudi, L., Kahn, B. B., Poulson, H. S., & Moses, H. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.8.4743 · Cited by 46
Gu, W., Tahir, S., Wang, Y.-C., Zhang, H.-C., Cherian, S. P., O'Connor, S. J. M., Leal, J. A., Rosenberg, S. H., & Ng, S. C. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00132-x · Cited by 46
Nguyen, K. T., Wang, W.-J., Chan, J. L. ‐., & Wang, L. (2000) · Oncogene · doi:10.1038/sj.onc.1203911 · Cited by 46
Law, B. K., Nørgaard, P. H., & Moses, H. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.10796 · Cited by 45
Effects of flwastatin on growth of porcine and human vascular smooth muscle cells in vitro
Rogler, G., Lackner, K. J., & Schmitz, G. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(05)80031-1 · Cited by 45
Lipophilic statins induce apoptosis of human vascular smooth muscle cells
Guijarro, C., Blanco‐Colio, L. M., Massy, Z. A., et al. (1999) · Kidney International · doi:10.1038/sj.ki.4495409 · Cited by 45
Does Lowering Cholesterol Cause Cancer?
Dalen, J. E. (1996) · JAMA · doi:10.1001/jama.1996.03530250071030 · Cited by 44
Sizemore, N., Cox, A. D., Barnard, J. A., Oldham, S., Reynolds, E. R., Der, C. J., & Coffey, R. J. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70449-x · Cited by 43
Russo, P., Malacarne, D., Falugi, C., Trombino, S., & O'Connor, P. M. (2002) · International Journal of Cancer · doi:10.1002/ijc.10461 · Cited by 43
Gene Trapping Identifies Inhibitors of Oncogenic Transformation
AndreuÖ, T., Beckers, T. L., Thoenes, E., Hilgard, P., & von Melchner, H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13848 · Cited by 43
Suzuki, N., Villar, K. D., & Tamanoi, F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10499 · Cited by 43
Kikuchi, T., Nagata, Y., & Abe, T. (1997) · Journal of Neuro-Oncology · doi:10.1023/a:1005753523949 · Cited by 42
Xu, X., McGuire, T. F., Blaskovich, M. A., Sebti, S. M., & Romero, G. G. (1996) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1996.0070 · Cited by 42
Marley, S. B., Davidson, R. J., Goldman, J. M., & Gordon, M. Y. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03237.x · Cited by 40
Takata, M., Urakaze, M., Temaru, R., Yamazaki, K., Nakamura, N., Nobata, Y., Kishida, M., Sato, A., & Kobayashi, M. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704305 · Cited by 39
Increased sensitivity of multidrug-resistant myeloid leukemia cell lines to lovastatin
Maksumova, L., Ohnishi, K., Muratkhodjaev, F., Zhang, W., Pan, L., Takeshita, A., & Ohno, R. (2000) · Leukemia · doi:10.1038/sj.leu.2401856 · Cited by 37
Nielsen, L. L., Shi, B., Hajian, G., Yaremko, B., Lipari, P., Ferrari, E., Gurnani, M., Malkowski, M. G., Chen, J., Bishop, W. R., et al. (1999) · PubMed · Cited by 36
Molecular multitasking: statins lead to more arteries, less plaque
Simons, M. (2000) · Nature Medicine · doi:10.1038/79646 · Cited by 36
Apoptosis of medulloblastoma cellsIn vitro follows inhibition of farnesylation using manumycin A
Wang, W., & Macaulay, R. J. B. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990730)82:3<430::aid-ijc17>3.0.co;2-9 · Cited by 36
Mantha, A. J., McFee, K. E., Niknejad, N., Goss, G. D., Lorimer, I. A. J., & Dimitroulakos, J. (2003) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-003-0490-2 · Cited by 34
Charvat, S., Duchesne, M., Parvaz, P., Chignol, M. C., Schmitt, D., & Serres, M. (1999) · PubMed · Cited by 34
Ha-rasVal12Oncogene Increases Susceptibility of NIH/3T3 Cells to Lovastatin
Chang, M.-Y., Jan, M., Won, S., & Liu, H. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8911 · Cited by 33
Zhang, Z., Wang, Y., Lantry, L. E., Kastens, E., Liu, G., Hamilton, A. D., Sebti, S. M., Lubet, R. A., & You, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206630 · Cited by 33
Kim, J.-S., Pirnia, F., Choi, Y. H., Nguyen, P. M., Knepper, B., Tsokos, M., Schulte, T. W., Birrer, M. J., Blagosklonny, M. V., Schaefer, O., et al. (2000) · Oncogene · doi:10.1038/sj.onc.1204008 · Cited by 31
Brassard, D., English, J. M., Malkowski, M. G., Kirschmeier, P. T., Nagabhushan, T. L., & Bishop, W. R. (2002) · Experimental Cell Research · doi:10.1006/excr.2001.5440 · Cited by 30
Terano, T., Shiina, T., Noguchi, Y., et al. (1998) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat1994.5.1 · Cited by 27
Reuveni, H., Geiger, T., Geiger, B., & Levitzki, A. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.151.6.1179 · Cited by 26
Ghosh, P., Moyer, M. L., Mott, G. E., & Kreisberg, J. I. (1999) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19990915)74:4<532::aid-jcb3>3.0.co;2-e · Cited by 25
Suppression of tumorigenicity in Ras-transformed fibroblasts by alpha 2(I) collagen.
Travers, H., French, N. S., & Norton, J. D. (1996) · PubMed · Cited by 25
The Mevalonate Synthesis Pathway as a Therapeutic Target in Cancer
Andela, V. B., Pirri, M., Schwarz, E. M., Puzas, E. J., Keefe, R. J. O., Rosenblatt, J. D., & Rosier, R. N. (2003) · Clinical Orthopaedics and Related Research · doi:10.1097/01.blo.0000093846.72468.66 · Cited by 24
Murakami, M., Goto, T., Saito, Y., Goto, S., Kochi, M., & Ushio, Y. (2001) · International Journal of Oncology · doi:10.3892/ijo.19.3.525 · Cited by 23
Cholesterol, Cholesterogenesis and Cancer
Siperstein, M. D. (1995) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-1957-7_14 · Cited by 22
Synergism of Aminobisphosphonates and Farnesyl Transferase Inhibitors on Tumor Metastasis
Andela, V. B., Rosenblatt, J. D., Schwarz, E. M., Puzas, E. J., Keefe, R. J. O., & Rosier, R. N. (2002) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-200204000-00027 · Cited by 22
The Use of Molecular Markers in Farnesyltransferase Inhibitor (FTI) Therapy of Breast Cancer
Moasser, M. M., & Rosen, N. X. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1015209123900 · Cited by 22
New Molecular Targets of Breast Cancer Therapy
Sauer, G., Deißler, H., Kurzeder, C., & Kreienberg, R. (2002) · Strahlentherapie und Onkologie · doi:10.1007/s00066-002-0957-0 · Cited by 22
Hydroxymethylglutaryl-Coenzyme A Reductase Inhibitors in Osteoporosis Management
Coons, J. C. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a071 · Cited by 22
Mevalonate Prevents Lovastatin-Induced Apoptosis in Medulloblastoma Cell Lines
Wang, W., & Macaulay, R. J. B. (1999) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100000433 · Cited by 22
Rao, S., Gray-Bablin, J., Herliczek, T. W., & Keyomarsi, K. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4620 · Cited by 21
Statins may potentiate bisphosphonates anticancer properties: a new pharmacological approach?
Vincenzi, B., Santini, D., Avvisati, G., Baldi, A., Cesa, A. L., & Tonini, G. (2003) · Medical Hypotheses · doi:10.1016/s0306-9877(03)00124-5 · Cited by 19
Modulation of metastatic ability by inhibition of cholesterol synthesis
Kort, W. J., Hülsmann, W. C., & Stehman, T. E. M. (1989) · Clinical & Experimental Metastasis · doi:10.1007/bf01753812 · Cited by 19
Nakagawa, H., Mutoh, T., Kumano, T., & Kuriyama, M. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03021-6 · Cited by 16
Servais, P., Gulbis, B., Fokan, D., & Galand, P. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980518)76:4<601::aid-ijc25>3.0.co;2-8 · Cited by 16
Skaletz‐Rorowski, A., Müller, J. G., Kroke, A., Waltenberger, J. L., Pulawski, E., Pinkernell, K., & Breithardt, G. (2001) · European Journal of Cell Biology · doi:10.1078/0171-9335-00155 · Cited by 15
Du, W., Lebowitz, P. F., & Prendergast, G. C. (1999) · PubMed · Cited by 14
Russo, P., Ottoboni, C., Malacarne, D., Crippa, A., Riou, J., & O’Connor, P. M. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.1.220 · Cited by 6
Cited by
Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway
Freed-Pastor, W. A., Mizuno, H., Zhao, X., Langerød, A., Moon, S.-H., Rodriguez-Barrueco, R., Barsotti, A., Chicas, A., Li, W., Polotskaia, A., et al. (2012) · Cell · doi:10.1016/j.cell.2011.12.017 · Cited by 865
Demierre, M.-F., Higgins, P. D. R., Gruber, S. B., Hawk, E., & Lippman, S. M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1751 · Cited by 819
Hutchinson–Gilford progeria syndrome: Review of the phenotype
Hennekam, R. C. M. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31346 · Cited by 575
Exploiting the critical perioperative period to improve long-term cancer outcomes
Horowitz, M., Neeman, E., Sharon, E., & Ben-Eliyahu, S. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.224 · Cited by 487
Statin Drugs and Risk of Advanced Prostate Cancer
Platz, E. A., Leitzmann, M. F., Visvanathan, K., Rimm, E. B., Stampfer, M. J., Willett, W. C., & Giovannucci, E. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj499 · Cited by 406
Metadata
- Authors
- Graaf, M. R., Richel, D. J., van Noorden, C. J. F., & Guchelaar, H.-J.
- Venue
- Cancer Treatment Reviews
- Publisher
- Elsevier BV
- Published
- 2004-11
- Volume
- 30
- Issue
- 7
- Pages
- 609-641
- ISSN
- 0305-7372 (ISSN-L)
- OpenAlex
- W1966383174
- Cited by
- 300
- References
- 268
- FWCI
- 8.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.